{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:00:12Z","timestamp":1758052812758,"version":"3.44.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.clinbiochem.2012.12.011","type":"journal-article","created":{"date-parts":[[2012,12,20]],"date-time":"2012-12-20T07:46:21Z","timestamp":1355989581000},"page":"518-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma"],"prefix":"10.1016","volume":"46","author":[{"given":"A.C.","family":"Bougnoux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Solassol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0005","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1200\/JCO.2001.19.16.3635","article-title":"Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0010","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1136\/bmj.311.7019.1536","article-title":"Prognostic trees to aid prognosis in patients with cutaneous malignant melanoma. Scottish Melanoma Group","volume":"311","author":"Aitchison","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0015","doi-asserted-by":"crossref","first-page":"10652","DOI":"10.1158\/0008-5472.CAN-06-0921","article-title":"Markers and tissue resources for melanoma: meeting report","volume":"66","author":"Becker","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0020","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/j.ejca.2009.04.016","article-title":"LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951)","volume":"45","author":"Agarwala","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0025","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1200\/JCO.1998.16.3.1103","article-title":"Prognostic factors for survival of patients treated systemically for disseminated melanoma","volume":"16","author":"Eton","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0361-9230(95)00040-2","article-title":"The S100 protein family: history, function, and expression","volume":"37","author":"Zimmer","year":"1995","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0035","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1200\/JCO.2001.19.3.824","article-title":"Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma","volume":"19","author":"Martenson","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00008390-200302000-00008","article-title":"Serum S100B is suitable for prediction and monitoring of response to chemoimmunotherapy in metastatic malignant melanoma","volume":"13","author":"Hamberg","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0045","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.ejca.2004.10.019","article-title":"Normal values of serum S-100B predict prolonged survival for stage IV melanoma patients","volume":"41","author":"Smit","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0050","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000011989","article-title":"S100B protein detection in serum is a significant prognostic factor in metastatic melanoma","volume":"56","author":"Hauschild","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/CMR.0b013e32831993cc","article-title":"Prospective monitoring of adjuvant treatment in high-risk melanoma patients: lactate dehydrogenase and protein S-100B as indicators of relapse","volume":"19","author":"Egberts","year":"2009","journal-title":"Melanoma Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0060","first-page":"513","article-title":"Elevation of a serum component in neoplastic disease","volume":"14","author":"Hill","year":"1954","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0065","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0070","first-page":"643","article-title":"Proteomic strategies for biomarker identification: progress and challenges","volume":"2","author":"Fung","year":"2000","journal-title":"Curr Opin Mol Ther"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0075","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1586\/14789450.3.3.311","article-title":"Clinical proteomics and mass spectrometry profiling for cancer detection","volume":"3","author":"Solassol","year":"2006","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0080","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/978-1-59745-117-8_7","article-title":"MALDI\/SELDI protein profiling of serum for the identification of cancer biomarkers","volume":"428","author":"Cazares","year":"2008","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0085","doi-asserted-by":"crossref","first-page":"5088","DOI":"10.1200\/JCO.2005.03.164","article-title":"Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients","volume":"23","author":"Mian","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1196\/annals.1318.047","article-title":"Detection of differentially expressed proteins in early-stage melanoma patients using SELDI-TOF mass spectrometry","volume":"1022","author":"Wilson","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0095","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1200\/JCO.2008.18.0554","article-title":"Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling","volume":"27","author":"Findeisen","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0100","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/1522-2683(20000701)21:13<2641::AID-ELPS2641>3.0.CO;2-5","article-title":"A microarray enzyme-linked immunosorbent assay for autoimmune diagnostics","volume":"21","author":"Joos","year":"2000","journal-title":"Electrophoresis"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0105","doi-asserted-by":"crossref","first-page":"e5199","DOI":"10.1371\/journal.pone.0005199","article-title":"Proteome serological determination of tumor-associated antigens in melanoma","volume":"4","author":"Forgber","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0110","first-page":"17","article-title":"Identification of melanoma antigens using a Serological Proteome Approach (SERPA)","volume":"7","author":"Suzuki","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0115","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1021\/pr100856k","article-title":"Serum autoantibody profiling using a natural glycoprotein microarray for the prognosis of early melanoma","volume":"9","author":"Liu","year":"2010","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0120","doi-asserted-by":"crossref","first-page":"19178","DOI":"10.1021\/ja207515j","article-title":"Multifunctional core-shell nanoparticles: discovery of previously invisible biomarkers","volume":"133","author":"Tamburro","year":"2011","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1600-0625.2010.01187.x","article-title":"A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum","volume":"20","author":"Longo","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0130","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/pr7007175","article-title":"Absolute SILAC for accurate quantitation of proteins in complex mixtures down to the attomole level","volume":"7","author":"Hanke","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0135","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1074\/mcp.M700440-MCP200","article-title":"Relative protein quantification by isobaric SILAC with immonium ion splitting (ISIS)","volume":"7","author":"Colzani","year":"2008","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0140","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1073\/pnas.1017228108","article-title":"CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0145","doi-asserted-by":"crossref","first-page":"4107","DOI":"10.1021\/pr800174k","article-title":"Comparative proteomic analysis of matched primary and metastatic melanoma cell lines","volume":"7","author":"Al-Ghoul","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.clim.2005.05.004","article-title":"Cyclophilin A may contribute to the inflammatory processes in rheumatoid arthritis through induction of matrix degrading enzymes and inflammatory cytokines from macrophages","volume":"116","author":"Kim","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0155","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbapap.2008.09.014","article-title":"Proteomic studies of B16 lines: involvement of annexin A1 in melanoma dissemination","volume":"1794","author":"Rondepierre","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0160","first-page":"6716","article-title":"Functional proteomic analysis of melanoma progression","volume":"63","author":"Bernard","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0165","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.4161\/cc.10.17.17068","article-title":"Characterization of human melanoma cell lines and melanocytes by proteome analysis","volume":"10","author":"Caputo","year":"2011","journal-title":"Cell Cycle"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0170","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1021\/pr8010827","article-title":"Entering a new era of rational biomarker discovery for early detection of melanoma metastases: secretome analysis of associated stroma cells","volume":"8","author":"Paulitschke","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0175","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1021\/pr800745e","article-title":"Selective expression of Syntaxin-7 protein in benign melanocytes and malignant melanoma","volume":"8","author":"Stromberg","year":"2009","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0180","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jprot.2011.04.013","article-title":"Protein signatures for survival and recurrence in metastatic melanoma","volume":"74","author":"Hardesty","year":"2011","journal-title":"J Proteomics"},{"key":"10.1016\/j.clinbiochem.2012.12.011_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ccr.2011.08.021","article-title":"Cancer biomarkers: closer to delivering on their promise","volume":"20","author":"Liotta","year":"2011","journal-title":"Cancer Cell"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912012006996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:40:44Z","timestamp":1757864444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912012006996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0009912012006996"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.12.011","relation":{},"ISSN":["0009-9120"],"issn-type":[{"type":"print","value":"0009-9120"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of proteomics to the identification of biomarkers for cutaneous malignant melanoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2012.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}